Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB-WT) Invested Capital (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Invested Capital for 3 consecutive years, with $352.9 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 24.92% to $352.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $352.9 million through Dec 2025, down 24.92% year-over-year, with the annual reading at $352.9 million for FY2025, 24.92% down from the prior year.
  • Invested Capital for Q4 2025 was $352.9 million at Nuvation Bio, up from $331.5 million in the prior quarter.
  • The five-year high for Invested Capital was $641.1 million in Q1 2023, with the low at $268.8 million in Q2 2024.
  • Average Invested Capital over 3 years is $484.5 million, with a median of $490.6 million recorded in 2024.
  • The sharpest move saw Invested Capital tumbled 56.96% in 2024, then skyrocketed 40.79% in 2025.
  • Over 3 years, Invested Capital stood at $605.1 million in 2023, then fell by 22.32% to $470.1 million in 2024, then dropped by 24.92% to $352.9 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $352.9 million, $331.5 million, and $378.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.